64 related articles for article (PubMed ID: 2954596)
1. [Changes in the content and structure of the coenzyme A moiety in the liver of diabetic mice (db/db) administered a regimen of nicotinamide].
Obrosova IG; Moĭseenok AG; Efimov AS; Sheĭbak VM; Chiger VB
Biull Eksp Biol Med; 1987 May; 103(5):560-2. PubMed ID: 2954596
[TBL] [Abstract][Full Text] [Related]
2. [Coa biosynthesis and the structure of its reserve in the liver in mice with diabetes (db/db) after administration of pantothenic acid derivatives].
Moiseenok AG; Efimov AS; Sheĭbak VM; Obrosova IG; Gurinovich VA
Probl Endokrinol (Mosk); 1987; 33(6):45-9. PubMed ID: 3438267
[TBL] [Abstract][Full Text] [Related]
3. [Nicotinamide coenzymes in the regulation of cellular metabolism in various types of diabetes].
Velikiĭ NN; Obrosova IG; Efimov AS; Babicheva EI; Sokil OP
Vopr Med Khim; 1992; 38(4):45-52. PubMed ID: 1462505
[TBL] [Abstract][Full Text] [Related]
4. [Effect of phosphopantothenate on the biosynthesis of cholesterol and its esters from various precursors in the liver of db/db mice].
Obrosova IG; Ostrovskiĭ IuM; Tsyruk VL; Moiseenok AG; Efimov AS
Biokhimiia; 1988 Nov; 53(11):1797-802. PubMed ID: 3251547
[TBL] [Abstract][Full Text] [Related]
5. [Enzyme systems of the substrate and cofactor supply of hyperlipogenesis in non-insulin-dependent diabetes].
Obrosova IG; Efimov AS; Velikiĭ NN; Zimatkina TI; Moiseenok AG
Biull Eksp Biol Med; 1988 May; 105(5):549-52. PubMed ID: 2898264
[TBL] [Abstract][Full Text] [Related]
6. Acceleration of the development of diabetes in obese diabetic (db/db) mice by nicotinamide: a comparison with its antidiabetic effects in non-obese diabetic mice.
Piercy V; Toseland CD; Turner NC
Metabolism; 2000 Dec; 49(12):1548-54. PubMed ID: 11145115
[TBL] [Abstract][Full Text] [Related]
7. [Hypolipidemic effect of the antivitamin B1 oxythiamine in diabetic mice (db/db)].
Obrosova IG; Larin FS; Efimov AS; Tron'ko ND; Tsyruk VL
Vopr Med Khim; 1987; 33(6):47-51. PubMed ID: 3445544
[TBL] [Abstract][Full Text] [Related]
8. Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity.
Kim WS; Lee YS; Cha SH; Jeong HW; Choe SS; Lee MR; Oh GT; Park HS; Lee KU; Lane MD; Kim JB
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E812-9. PubMed ID: 19176354
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice.
Yamanaka M; Itakura Y; Tsuchida A; Nakagawa T; Noguchi H; Taiji M
Diabetes Obes Metab; 2007 Nov; 9(6):879-88. PubMed ID: 17924870
[TBL] [Abstract][Full Text] [Related]
10. Separate influences of insulin and hyperglycemia on hepatic drug metabolism in mice with genetic and chemically induced diabetes mellitus.
Knodell RG; Handwerger BS; Morley JE; Levine AS; Brown DM
J Pharmacol Exp Ther; 1984 Jul; 230(1):256-62. PubMed ID: 6379147
[TBL] [Abstract][Full Text] [Related]
11. Hypoglycemic and hypolipidemic action of Du-zhong (Eucommia ulmoides Oliver) leaves water extract in C57BL/KsJ-db/db mice.
Park SA; Choi MS; Kim MJ; Jung UJ; Kim HJ; Park KK; Noh HJ; Park HM; Park YB; Lee JS; Lee MK
J Ethnopharmacol; 2006 Oct; 107(3):412-7. PubMed ID: 16684593
[TBL] [Abstract][Full Text] [Related]
12. Effects of the novel oral antidiabetic agent HQL-975 on glucose and lipid metabolism in diabetic db/db mice.
Ishikawa Y; Watanabe K; Takeno H; Tani T
Arzneimittelforschung; 1998 Mar; 48(3):245-50. PubMed ID: 9553681
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of liver fatty acid oxidation in the leptin-deficient obese mouse.
Brix AE; Elgavish A; Nagy TR; Gower BA; Rhead WJ; Wood PA
Mol Genet Metab; 2002 Mar; 75(3):219-26. PubMed ID: 11914033
[TBL] [Abstract][Full Text] [Related]
14. Hepatic CoA, S-acyl-CoA, biosynthetic precursors of the coenzyme and pantothenate-protein complexes in dietary pantothenic acid deficiency.
Moiseenok AG; Sheibak VM; Gurinovich VA
Int J Vitam Nutr Res; 1987; 57(1):71-7. PubMed ID: 3583597
[TBL] [Abstract][Full Text] [Related]
15. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
[TBL] [Abstract][Full Text] [Related]
16. Acyl-coenzyme A binding protein expression alters liver fatty acyl-coenzyme A metabolism.
Huang H; Atshaves BP; Frolov A; Kier AB; Schroeder F
Biochemistry; 2005 Aug; 44(30):10282-97. PubMed ID: 16042405
[TBL] [Abstract][Full Text] [Related]
17. [The action of nicotinamide on the adenine nucleotide system as well as on mitochondrial oxidation and phosphorylation processes in the liver of db/db strain mice].
Obrosova IG; Kirput' SN; Ostrovskiĭ IuM; Larin FS; Efimov AS
Biull Eksp Biol Med; 1988 Dec; 106(12):681-3. PubMed ID: 2974733
[TBL] [Abstract][Full Text] [Related]
18. Osthole, a potential antidiabetic agent, alleviates hyperglycemia in db/db mice.
Liang HJ; Suk FM; Wang CK; Hung LF; Liu DZ; Chen NQ; Chen YC; Chang CC; Liang YC
Chem Biol Interact; 2009 Oct; 181(3):309-15. PubMed ID: 19682441
[TBL] [Abstract][Full Text] [Related]
19. Effects of fenofibrate and insulin on the biosynthesis of unsaturated fatty acids in streptozotocin diabetic rats.
Montanaro MA; Bernasconi AM; González MS; Rimoldi OJ; Brenner RR
Prostaglandins Leukot Essent Fatty Acids; 2005 Nov; 73(5):369-78. PubMed ID: 16099631
[TBL] [Abstract][Full Text] [Related]
20. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.
Bandyopadhyay GK; Yu JG; Ofrecio J; Olefsky JM
Diabetes; 2006 Aug; 55(8):2277-85. PubMed ID: 16873691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
